Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment
Chemistry & Biodiversity · 2025-08 · 22 (8)
DOI: 10.1002/cbdv.202402479 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 11.06.2025. Verfasst von Alaa A A Aljabali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid, Jordan. Hauptthemen laut MEDLINE: Phytochemicals, Neoplasms, Antineoplastic Agents, Phytogenic, Precision Medicine. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a major global health concern. Therefore, new treatment options are needed. The phytochemicals have different chemical structures. It also exhibits several other biological activities. Therefore, these compounds are promising anticancer agents. This review aims to identify and assess new candidates for anticancer therapy. Researchers have identified these compounds among the well‐studied plant chemicals and their actions. Thus, these compounds can be used in anticancer therapies. The popularity of phytochemicals has grown. Currently, these are the subjects of extensive investigational studies. However, obstacles remain in its development and translation for clinical use. This is especially true for low bioavailability. These compounds also exhibit a wide range of activities, toxicities, and regulatory activities. These are necessary for the isolation and characterization of phytochemicals. This review discusses these challenges and the recent progress. Emphasis has been placed on integrating traditional knowledge of medicines with current biomedical advancements to augment the efficacy of phytoconstituents for cancer treatment. The review indicates new treatment frameworks with the synergy of traditional systems of medicine (e.g., Traditional Chinese Medicine [TCM] and Ayurveda) and new approaches today, such as nanotechnology and artificial intelligence‐assisted drug discovery. This review also highlights the clinical efficacy of such phytoconstituents and addresses key developmental bottlenecks, such as bioavailability, regulatory barriers, and standardized methods of extraction. These include the extraction methods, delivery systems, and clinical findings. It focuses on the merging of modern and traditional medicine. The goal of this study was to maximize the potential of these phytochemicals. This will help to create successful cancer treatments. A thorough analysis was done using primary databases, namely PubMed, Scopus, Web of Science, and Google Scholar, for articles between 2020 and 2023. The relevant literature was searched using keywords such as phytochemicals, anticancer mechanisms, bioavailability, delivery systems, and clinical efficacy. The selected articles included peer‐reviewed studies that compared the anticancer mechanisms of phytochemicals, challenges encountered in their development, new advances in extraction and delivery technologies, and clinical reports of their therapeutic efficacy. This approach allowed a wide synthesis of existing knowledge around phytochemicals as anticancer drugs. This review summarizes our knowledge of phytochemicals as potential anticancer agents. This finding fills a gap in the literature. This offers new insights into their roles in personalized cancer treatment. This explains the mechanisms of action and challenges in development. This places these compounds at the forefront of, and complements, cancer treatment. Considerable research is required to boost personalized oncology research. This leads to improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid, Jordan.
- Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.
- Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Zarqa, Jordan.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
ORCID-Profile: Alaa A A Aljabali, Taher Hatahet
Zitieren
APA
Aljabali, A. A. A., Obeid, M. A., Bashatwah, R. M., Qnais, E., Gammoh, O., Alqudah, A., Mishra, V., Mishra, Y., Khan, M. A., Parvez, S., El-Tanani, M., & Hatahet, T. (2025). Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment. Chemistry & Biodiversity, 22(8). https://doi.org/10.1002/cbdv.202402479
Vancouver
Aljabali AAA, Obeid MA, Bashatwah RM, Qnais E, Gammoh O, Alqudah A, et al. Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment. Chemistry & Biodiversity. 2025;22(8). doi:10.1002/cbdv.202402479
BibTeX
@article{Aljabali2025,
author = {Aljabali, Alaa A A and Obeid, Mohammad A and Bashatwah, Rasha M and Qnais, Esam and Gammoh, Omar and Alqudah, Abdelrahim and Mishra, Vijay and Mishra, Yachana and Khan, Mohammad Ahmed and Parvez, Suhel and El-Tanani, Mohamed and Hatahet, Taher},
title = {Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {8},
doi = {10.1002/cbdv.202402479}
}
EUVIMED